Relationship of adipocyte fatty acid-binding protein to adiponectin ratio with femoral intima-media thickness and endothelium-dependent vasodilation in patients with newly-diagnosed type 2 diabetes mellitus

National Medical Journal of China

Volumn 90, Issue 4, 2010, Pages 231-235

  Xiao, Yang ^a   Yao, Lan ^a   Li, Xing ^a   Zhong, Hui ^a   Chen, Xiao Yan ^a   Tang, Wei Li ^a   Liu, Shi Ping ^a   Xu, Ai Min ^b   Zhou, Zhi Guang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b NONE

Author keywords

Adiponectin; Diabetes mellitus, type 2; Tunica media; Vasodilation

Indexed keywords

ADIPONECTIN; FATTY ACID BINDING PROTEIN; ENDOTHELIUM DERIVED RELAXING FACTOR;

ADIPOCYTE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRACHIAL ARTERY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMORAL ARTERY; HUMAN; HUMAN TISSUE; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; VASODILATATION; AGED; BLOOD; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADIPONECTIN; AGED; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FATTY ACID-BINDING PROTEINS; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED;

EID: 84871415382     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.04.006     Document Type: Article

References (18)

1. Giannoukas A D, Antoniou G A, Saleptsis V, et al. Common femoral artery intima-media thickness as marker for cardiovascular disease in asymptomatic adults. Vasa, 2009, 38:147-154.
2. Rask-Madsen C, King G L. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab, 2007, 3:46-56.
3. Xu A, Wang Y, Xu J Y, et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem, 2006, 52:405-413.
4. Tso A W, Xu A, Sham P C, et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care, 2007, 30:2667-2672.
5. Okamoto Y, Kihara S, Ouchi N, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation, 2002, 106:2767-2770.
6. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999, 100:2473-2476.
7. Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem, 2002, 277:37487-37491.
8. Yeung D C, Xu A, Cheung C W, et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol, 2007, 27: 1796-1802.
9. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 2001, 86: 1930-1935.
10. Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol, 2003, 23:85-89.
11. Tan K C, Xu A, Chow W S, et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab, 2004, 89:765-769.
12. Berg A H, Scherer P E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res, 2005, 96:939-949.
13. Makowski L, Boord J B, Maeda K, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med, 2001, 7: 699-705.
14. Boord J B, Maeda K, Makowski L, et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation, 2004, 110:1492-1498.
15. Boord J B, Maeda K, Makowski L, et al. Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol, 2002, 22:1686-1691.
16. Tuncman G, Erbay E, Hom X, et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci U S A, 2006, 103:6970-6975.
17. Hertzel A V, Smith L A, Berg A H, et al. Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am J Physiol Endocrinol Metab, 2006, 290:E814-823.
18. Maeda K, Cao H, Kono K, et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab, 2005, 1:107-119.